Healthcare provider profile · identity verified

Cybele D Johnson, DO

Internal Medicine · SHAKOPEE, MN · NPI 1942492988

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	219	62
Levothyroxine Sodium	Levothyroxine Sodium	171	42
Potassium Chloride	Potassium Chloride	145	38
Metoprolol Succinate	Metoprolol Succinate	143	35
Amlodipine Besylate	Amlodipine Besylate	136	40
Omeprazole	Omeprazole	133	43
Losartan Potassium	Losartan Potassium	132	44
Lisinopril	Lisinopril	124	38
Atorvastatin Calcium	Atorvastatin Calcium	114	34
Furosemide	Furosemide	110	35
Gabapentin	Gabapentin	102	38
Sertraline Hcl	Sertraline Hcl	93	21
Spironolactone	Spironolactone	92	27
Montelukast Sodium	Montelukast Sodium	86	22
Pantoprazole Sodium	Pantoprazole Sodium	84	25
Famotidine	Famotidine	81	17
Torsemide	Torsemide	81	28
Buspirone Hcl	Buspirone Hcl	74	14
Oxycodone Hcl	Oxycodone Hcl	72	18
Hydrochlorothiazide	Hydrochlorothiazide	67	15
Tamsulosin Hcl	Tamsulosin Hcl	67	16
Alendronate Sodium	Alendronate Sodium	62	17
Trulicity	Dulaglutide	59	suppressed
Allopurinol	Allopurinol	58	19
Fluoxetine Hcl	Fluoxetine Hcl	57	14
Pregabalin	Pregabalin	56	24
Metformin Hcl Er	Metformin Hcl	55	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	16
Duloxetine Hcl	Duloxetine Hcl	50	16
Venlafaxine Hcl Er	Venlafaxine Hcl	50	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	21
Carvedilol	Carvedilol	46	14
Hydroxyzine Hcl	Hydroxyzine Hcl	43	17
Fluticasone Propionate	Fluticasone Propionate	42	14
Simvastatin	Simvastatin	41	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	11
Eliquis	Apixaban	38	11
Albuterol Sulfate Hfa	Albuterol Sulfate	37	20
Bupropion Xl	Bupropion Hcl	37	suppressed
Spiriva Respimat	Tiotropium Bromide	37	suppressed
Ventolin Hfa	Albuterol Sulfate	36	11
Warfarin Sodium	Warfarin Sodium	36	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	suppressed
Trazodone Hcl	Trazodone Hcl	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Nystatin	Nystatin	32	17
Celecoxib	Celecoxib	31	suppressed
Azelastine Hcl	Azelastine Hcl	30	suppressed
Glipizide Er	Glipizide	30	12
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Metformin Hcl	Metformin Hcl	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	13
Jantoven	Warfarin Sodium	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Ozempic	Semaglutide	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Metolazone	Metolazone	24	suppressed
Tramadol Hcl	Tramadol Hcl	23	12
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	21	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Lorazepam	Lorazepam	21	12
Myrbetriq	Mirabegron	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Glipizide	Glipizide	19	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	18	suppressed
Trospium Chloride	Trospium Chloride	18	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Atenolol	Atenolol	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Estradiol	Estradiol	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Topiramate	Topiramate	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Prednisone	Prednisone	14	12
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Clotrimazole	Clotrimazole	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Methimazole	Methimazole	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Baclofen	Baclofen	11	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error